The Rising Tide of GLP-1 Costs: Can Your Health Plan Stay Afloat? [what do dieting pills do]

The Rising Tide of GLP-1 Costs: Can Your Health Plan Stay Afloat? [what do dieting pills do]

| 1h 28m 28s | Video has closed captioning.

If one pharmacist calls another and asks if they have any of this year’s most popular drug, they don’t even have to say a name. It’s probably a GLP-1. About 12% of U.S. adults have taken some type of glucagon-like peptide agonist medication. Drugs like Ozempic, Wegovy, Mounjaro, Zepbound, or their compounded identical generics (like semaglutide injections) are popular because of their effectiveness and in spite of their usually high cost. The big question is, how should health plans handle these increasing costs? HaloScrips pharmacists Phil Baker and Michell Zulu weighed in on these drugs, including the health considerations, costs, coverage options and more. Read their article on the subject or to download a PDF: